HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced today that the results of an important pediatric second-hand smoke study of the Company's NicAlert™ product will be the subject of a podium presentation by Professor Anne Turner Henson of the University of Alabama at the International Conference of the American Thoracic Society in San Francisco on May 20, 2007. The study involved 100 pre-school children who were investigated for second-hand smoke exposure, smokers in the family, and other health issues.
